Addressing the Gap in the Management of Patients After Acute Myocardial Infarction: How Good Is the Evidence Supporting Current Treatment Guidelines?ByMichael B. Fowler, MB, FRCPOctober 1st 2004
Safety and Statins: Pharmacologic and Clinical PerspectivesByMichael B. Bottorff, PharmDOctober 1st 2004
Neurohormones and the Progression of Cardiovascular Disease: What's Behind High Risk?ByWilliam T. Abraham, MDOctober 1st 2004
Role of Neurohormonal Antagonists in Management of Patients With Hypertension, Metabolic Syndrome, and DiabetesByGregg C. Fonarow, MDOctober 1st 2004
